CVS Health Total Liabilities & Equity decreased by 0.7% to $253.54B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.1%, from $253.22B to $253.54B. Over 5 years (FY 2020 to FY 2025), Total Liabilities & Equity shows relatively stable performance with a 1.9% CAGR.
An increase typically reflects overall balance sheet growth or expansion of the company's asset base, while a decrease may indicate divestitures or debt repayment.
This represents the sum of all claims against a company's assets, combining obligations to external creditors and the re...
This is a standard accounting identity used across all industries to verify that assets equal the sum of liabilities and equity.
total_liabilities_and_equity| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $231.16B | $234.89B | $233.00B | $232.87B | $230.28B | $231.21B | $228.28B | $239.33B | $250.07B | $251.31B | $249.73B | $249.74B | $252.48B | $252.43B | $253.22B | $255.59B | $258.34B | $255.33B | $253.54B |
| QoQ Change | — | +1.6% | -0.8% | -0.1% | -1.1% | +0.4% | -1.3% | +4.8% | +4.5% | +0.5% | -0.6% | +0.0% | +1.1% | -0.0% | +0.3% | +0.9% | +1.1% | -1.2% | -0.7% |
| YoY Change | — | — | — | — | -0.4% | -1.6% | -2.0% | +2.8% | +8.6% | +8.7% | +9.4% | +4.4% | +1.0% | +0.4% | +1.4% | +2.3% | +2.3% | +1.1% | +0.1% |